210 related articles for article (PubMed ID: 3531424)
21. A comparison of carboplatin plus methotrexate versus methotrexate alone in patients with recurrent and metastatic head and neck cancer.
Eisenberger M; Krasnow S; Ellenberg S; Silva H; Abrams J; Sinibaldi V; Van Echo D; Aisner J
J Clin Oncol; 1989 Sep; 7(9):1341-5. PubMed ID: 2671289
[TBL] [Abstract][Full Text] [Related]
22. Bleomycin, epirubicin, carboplatin (BECA) in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Adamo V; Maisano R; Pergolizzi S; Altavilla G; Caristi N; Chiofalo G; Scimone A; Settineri N
J Chemother; 1997 Feb; 9(1):72-6. PubMed ID: 9106022
[TBL] [Abstract][Full Text] [Related]
23. A phase I-II trial of induction chemotherapy with carboplatin and fluorouracil in locally advanced head and neck squamous cell carcinoma: a report from the UCL-Oncology Group, Belgium.
Grégoire V; Beauduin M; Humblet Y; Hamoir M; Longueville J; Majois F; Remacle FM; Rousseau F; Salamon E; Wambersie A
J Clin Oncol; 1991 Aug; 9(8):1385-92. PubMed ID: 2072142
[TBL] [Abstract][Full Text] [Related]
24. Clinical phase I study of paclitaxel followed by cisplatin in advanced head and neck squamous cell carcinoma.
Hanauske AR; Schilling T; Heinrich B; Kau R; Herzog M; Quasthoff S; Bochtler H; Diergarten K; Rastetter J
Semin Oncol; 1995 Dec; 22(6 Suppl 14):35-9. PubMed ID: 8553082
[TBL] [Abstract][Full Text] [Related]
25. Phase I-II trial with cisplatin and 5-FU in recurrent head and neck cancer: an effective outpatient schedule.
Merlano M; Tatarek R; Grimaldi A; Margarino G; Rosso R
Cancer Treat Rep; 1985 Sep; 69(9):961-4. PubMed ID: 4040809
[TBL] [Abstract][Full Text] [Related]
26. Docetaxel and platinum combination chemotherapy in locally advanced or metastatic head and neck cancer.
Kucukzeybek Y; Gorumlu G; Karaca B; Erten C; Cengiz E; Kemal Gul M; Karabulut B; Uslu R; Sanli UA; Goker E
J BUON; 2008; 13(2):199-203. PubMed ID: 18555465
[TBL] [Abstract][Full Text] [Related]
27. A clinical screening cooperative group phase II evaluation of lobaplatin (ASTA D-19466) in advanced head and neck cancer.
Degardin M; Armand JP; Chevallier B; Cappelaere P; Lentz MA; David M; Roché H
Invest New Drugs; 1995; 13(3):253-5. PubMed ID: 8729955
[TBL] [Abstract][Full Text] [Related]
28. Carboplatin: a new platinum analog in the treatment of epidermoid carcinoma of the esophagus.
Sternberg C; Kelsen D; Dukeman M; Leichman L; Heelan R
Cancer Treat Rep; 1985 Nov; 69(11):1305-7. PubMed ID: 3912041
[TBL] [Abstract][Full Text] [Related]
29. Head and neck cancer: integrating anti-EGFR treatment with standard therapy.
Kies MS
J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S52-9. PubMed ID: 19780246
[TBL] [Abstract][Full Text] [Related]
30. Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma.
Shin DM; Glisson BS; Khuri FR; Ginsberg L; Papadimitrakopoulou V; Lee JJ; Lawhorn K; Gillenwater AM; Ang KK; Clayman GL; Callender DL; Hong WK; Lippman SM
J Clin Oncol; 1998 Apr; 16(4):1325-30. PubMed ID: 9552033
[TBL] [Abstract][Full Text] [Related]
31. A phase II study of carboplatin and paclitaxel for recurrent or metastatic head and neck cancer.
Ferrari D; Fiore J; Codecà C; Di Maria G; Bozzoni S; Bordin V; Caldiera S; Luciani A; Zonato S; Floriani I; Foa P
Anticancer Drugs; 2009 Mar; 20(3):185-90. PubMed ID: 19396017
[TBL] [Abstract][Full Text] [Related]
32. Cisplatin and 5-FU infusion chemotherapy in advanced, recurrent cancer of the head and neck: an Eastern Cooperative Oncology Group Pilot Study.
Rowland KM; Taylor SG; Spiers AS; DeConti RC; O'Donnell MR; Showel J; Stott PB; Milner LM; Marsh JC
Cancer Treat Rep; 1986 Apr; 70(4):461-4. PubMed ID: 3698038
[TBL] [Abstract][Full Text] [Related]
33. [An early phase II clinical study of cis-diammine glycolato platinum, 254-S, for head and neck cancers].
Inuyama Y; Miyake H; Horiuchi M; Hayasaki K; Komiyama S; Ota K
Gan To Kagaku Ryoho; 1992 Jun; 19(6):863-9. PubMed ID: 1605664
[TBL] [Abstract][Full Text] [Related]
34. Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Shin DM; Glisson BS; Khuri FR; Hong WK; Lippman SM
Semin Oncol; 1998 Apr; 25(2 Suppl 4):40-4; discussion 45-8. PubMed ID: 9578061
[TBL] [Abstract][Full Text] [Related]
35. Phase II study of carboplatin in patients with ovarian carcinoma: a National Cancer Institute of Canada Clinical Trials Group Study.
Eisenhauer EA; Swenerton KD; Sturgeon JF; Fine S; O'Reilly SE
Cancer Treat Rep; 1986 Oct; 70(10):1195-8. PubMed ID: 3530446
[TBL] [Abstract][Full Text] [Related]
36. S-1 monotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck after progression on platinum-based chemotherapy.
Yokota T; Onozawa Y; Boku N; Hamauchi S; Tsushima T; Taniguchi H; Todaka A; Machida N; Yamazaki K; Fukutomi A; Yasui H
Jpn J Clin Oncol; 2011 Dec; 41(12):1351-7. PubMed ID: 21980053
[TBL] [Abstract][Full Text] [Related]
37. Prospective randomized trial of high-dose cisplatin and fluorouracil infusion with or without sodium diethyldithiocarbamate in recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Paredes J; Hong WK; Felder TB; Dimery IW; Choksi AJ; Newman RA; Castellanos AM; Robbins KT; McCarthy K; Atkinson N
J Clin Oncol; 1988 Jun; 6(6):955-62. PubMed ID: 2836565
[TBL] [Abstract][Full Text] [Related]
38. [A combination of low-dose carboplatin (CBDCA) and radiation therapy in head and neck cancer patients--response and hematologenic toxicity].
Watanabe N; Kaneko T; Fujitani S; Umeyama M; Nomura Y; Zusho H; Yamada Y; Nanba G; Asahina N; Sugio Y; Okamoto Y; Daida T; Tokumaru T
Gan To Kagaku Ryoho; 1999 Jan; 26(1):101-6. PubMed ID: 9987505
[TBL] [Abstract][Full Text] [Related]
39. Carboplatin in the treatment of oesophageal cancer.
Mannell A; Winters Z
S Afr Med J; 1989 Sep; 76(5):213-4. PubMed ID: 2672377
[TBL] [Abstract][Full Text] [Related]
40. Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy.
Vermorken JB; Trigo J; Hitt R; Koralewski P; Diaz-Rubio E; Rolland F; Knecht R; Amellal N; Schueler A; Baselga J
J Clin Oncol; 2007 Jun; 25(16):2171-7. PubMed ID: 17538161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
